Your search returned 26 studies. (Get alerts for new studies):
- Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Study of KB004 in Subjects With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia (AML) - Acute Lymphocytic Leukemia (ALL) - Chronic Myelogenous Leukemia (CML) - Myelodysplastic Syndrome (MDS) - Myeloproliferative Neoplasms (MPN)
2 Locations available
- Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk
Conditions: Leukemia
1 Location available
- Zarnestra in Newly Diagnosed Acute Myelogenous Leukemia (AML)With 2 Gene Expression Signature Ratio
Conditions: Acute Myelogenous Leukemia
7 Locations available
- Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, an
Conditions: Acute Myelogenous Leukemia (AML) - Chronic Myelogenous Leukemia (CML) - Acute Lymphoblastic Leukemia (ALL) - Myelodysplastic Syndrome (MDS) - B Cell Malignancies
1 Location available
- 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Conditions: Leukemia
1 Location available
- Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL) - Acute Myelogenous Leukemia (AML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma - Hodgkin's Disease
2 Locations available
- Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM2)
Conditions: Acute Myelogenous Leukemia (AML)
3 Locations available
- Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations
Conditions: Acute Myelogenous Leukemia - Leukemia
1 Location available
- Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome
1 Location available
- Alvocidib (Flavopiridol), Ara-C and Mitoxantrone (FLAM) Versus "7+3" for Newly (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Improving Blood Stem Cell Collection and Transplant Procedures
Conditions: Myelodysplastic Syndrome (MDS) - Chronic Myelogenous Leukemia - Acute Lymphoblastic Leukemia - CML (Chronic Myelogenous Leukemia - CLL (Chronic Lymphocytic Leukemia) - Acute Myeloid Leukemia (AML)
1 Location available
- Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
Conditions: Non-Hodgkin's Lymphoma (NHL) - Hodgkin's Disease - Chronic Lymphocytic Leukemia (CLL) - Acute Myelogenous Leukemia (AML) - Acute Lymphoblastic Leukemia (ALL) - MDS
3 Locations available
- Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
Conditions: AML
2 Locations available
- TL32711 in Elderly Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML) - Leukemia, Acute Lymphocytic (ALL) - Leukemia, Chronic Myelogenous (CML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma (NHL)
1 Location available
- Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Conditions: Acute Myeloid Leukemia
2 Locations available
- Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
Conditions: Leukemia, Myeloid, Acute - Myelodysplastic Syndromes
1 Location available
- Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Conditions: Pediatric Acute Myelogenous Leukemia (AML)
15 Locations available
- Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in P
Conditions: Acute Myelogenous Leukemia (AML)
5 Locations available
- Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)
Conditions: Leukemia, Myeloid, Acute
1 Location available
- Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)
Conditions: Male and Female Subjects, Greater Than 60 Years of Age With Non-M3 AML
1 Location available
- Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
|